Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kalaris Therapeutics
(KLRS) Q1 2025
Earnings
KLRS
Mar 7
Confirmed
Q1 2025
-7.34
-5.81
-4.29
-2.76
Details
Expected EPS
-2.76
Actual EPS
-7.335
Surprise EPS
-4.58
Surprise Percent
-165.76%
Description
Kalaris Therapeutics (KLRS) has reported earnings of -7.335 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login